Molecular imaging of cancer: Applications of magnetic resonance methods

Proceedings of the IEEE

Volumn 93, Issue 4, 2005, Pages 784-798

  Gimi, Barjor ^a   Pathak, Arvind P ^a   Ackerstaff, Ellen ^a   Glunde, Kristine ^a   Artemov, Dmitri ^a   Bhujwalla, Zaver M ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cancer; Magnetic resonance imaging (MRI); Magnetic resonance spectroscopic imaging (MRSI); Metabolism; Molecular imaging; Receptor expression; Vascular imaging

Indexed keywords

AMPLIFICATION; ANTIBODIES; BLOOD; CELLS; DISEASES; MAGNETIC RESONANCE IMAGING; METABOLISM; OXYGEN; PH EFFECTS; PHYSIOLOGY; TUMORS;

MAGNETIC RESONANCE SPECTROSCOPIC IMAGING (MRSI); MOLECULAR IMAGING; RECEPTOR EXPRESSION; VASCULAR IMAGING;

MEDICAL IMAGING;

EID: 20744451715     PISSN: 00189219     EISSN: None     Source Type: Journal    
DOI: 10.1109/JPROC.2005.844266     Document Type: Conference Paper

References (135)

1. S. H. Koenig and R. D. Brown 3rd, "Relaxometry and MRI," in NMR in Physiology and Biomedicine, R. J. Gillies, Ed. San Diego, CA: Academic, 1994, p. 70.
2. P. Caravan, N. J. Cloutier, M. T. Greenfield, S. A. McDermid, S. U. Dunham, J. W. Bulte, J. C. Amedio, Jr., R. J. Looby, R. M. Supkowski, W. D. Horrocks, T. J. McMurry, and R. B. Lauffer, "The interaction of MS-325 with human serum albumin and its effect on proton relaxation rates," J. Amer. Chem. Soc., vol. 124, pp. 3152-3162, 2002.
3. E. Strable, J. W. Bulte, B. M. Moskowitz, K. Vivekanandan, M. Allen, and T. Douglas, "Synthesis and characterization of soluble iron oxide-dendrimer composites," Chem. Mater., vol. 13, pp. 2201-2209, 2001.
4. U. Schmiedl, M Ogan, H. Paajanen, M. Marotti, L. E. Crooks, A. C. Brito, and R. C. Brasch, "Albumin labeled with Gd-DTPA as an intravascular, blood pool-enhancing agent for MR imaging: Biodistribution and imaging studies," Radiology, vol. 162, pp. 205-210, 1987.
5. Z. M. Bhujwalla, D. Artemov, K. Natarajan, E. Ackerstaff, and M. Solaiyappan, "Vascular differences detected by MRI for metastatic versus nonmetastatic breast and prostate cancer xenografts," Neoplasia, vol. 3, pp. 1-11, 2000.
6. A. A. Bogdanov, Jr., R. Weissleder, H. W. Frank, A. V. Bogdanova, N. Nossif, B. K. Schaffer, E. Tsai, M. I. Papisov, and T. J. Brady, "A new macromolecule as a contrast agent for MR angiography: Preparation, properties, and animal studies," Radiology, vol. 187, pp. 701-706, 1993.
7. S. Gohr-Rosenthal, H. Schmitt-Willich, W. Ebert, and J. Conrad, "The demonstration of human tumors on nude mice using gadolinium-labeled monoclonal antibodies for magnetic resonance imaging," Invest. Radiol., vol. 28, pp. 789-795, 1993.
8. D. Artemov, N. Mon, R. Ravi, and Z. M. Bhujwalla, "Magnetic resonance molecular imaging of the Her-2/neu receptor," Cancer Res., vol. 63, pp. 2723-2727, 2003.
9. L. H. Bryant, Jr., M. W. Brechbiel, C. Wu, J. W. Bulte, V. Herynek, and J. A. Frank, "Synthesis and relaxometry of high-generation (G - 5, 7, 9, and 10) PAMAM dendrimer-DOTA-gadolinium chelates," J. Magn. Reson. Imag., vol. 9, pp. 348-352, 1999.
10. H. Kobayashi, S. Kawamoto, T. Saga, N. Sato, A. Hiraga, T. Ishimori, Y. Akita, M. H. Mamede, J. Konishi, K. Togashi, and M. W. Brechbiel, "Novel liver macromolecular MR contrast agent with a polypropylenimine diaminobutyl dendrimer core: Comparison to the vascular MR contrast agent with the polyamidoamine dendrimer core," Magn. Reson. Med., vol. 46, pp. 795-802, 2001.
11. D. A. Sipkins, D. A. Cheresh, M. R. Kazemi, L. M. Nevin, M. D. Bednarski, and K. C. Li, "Detection of tumor angiogenesis in vivo by alphaVbeta3-targeted magnetic resonance imaging," Nat. Med., vol. 4, pp. 623-626, 1998.
12. S. A. Anderson, R. K. Rader, W. F. Westlin, C. Null, D. Jackson, G. M. Lanza, S. A. Wickline, and J. J. Kotyk, "Magnetic resonance contrast enhancement of neovasculature with alpha(v)beta(3)-targeted nanoparticles," Magn. Reson. Med., vol. 44, pp. 433-439, 2000.
13. P. M. Winter, S. D. Caruthers, A. Kassner, T. D. Harris, L. K. Chinen, J. S. Allen, E. K. Lacy, H. Zhang, J. D. Robertson, S. A. Wickline, and G. M. Lanza, "Molecular imaging of angiogenesis in nascent Vx-2 rabbit tumors using a novel alpha(nu)beta3-targeted nanoparticle and 1.5 tesla magnetic resonance imaging," Cancer Res., vol. 63, pp. 5838-5843, 2003.
14. S. D. Konda, M. Aref, M. Brechbiel, and E. C. Wiener, "Development of a tumor-targeting MR contrast agent using the high-affinity folate receptor: Work in progress," Invest. Radial., vol. 35, pp. 50-57, 2000.
15. A. Y. Louie, M. M. Huber, E. T. Ahrens, U. Rothbacher, R. Moats, R. E. Jacobs, S. E. Fraser, and T. J. Meade, "In vivo visualization of gene expression using magnetic resonance imaging," Nat. Biotechnol., vol. 18, pp. 321-325, 2000.
16. A. Bogdanov, Jr., L. Matuszewski, C. Bremer, A. Petrovsky, and R. Weissleder, "Oligomerization of paramagnetic substrates result in signal amplification and can be used for MR imaging of molecular targets," Mol. Imag., vol. 1, pp. 16-23, 2002.
17. M. Gueron, "Nuclear relaxation in macromolecules by paramagnetic ions: A novel mechanism," J. Magn. Reson., vol. 19, pp. 58-66, 1975.
18. R. Weissleder, H. C. Cheng, A. Bogdanova, and A. Bogdanov, "Magnetically labeled cells can be detected by MR imaging," J. Magn. Reson. Imag., vol. 7, pp. 258-263, 1997.
19. S. J. Dodd, M. Williams, J. P. Suhan, D. S. Williams, A. P. Koretsky, and C. Ho, "Detection of single mammalian cells by high-resolution magnetic resonance imaging," Biophys. J., vol. 76, pp. 103-109, 1999.
20. J. W. Bulte, T. Douglas, B. Witwer, S. C. Zhang, E. Strable, B. K. Lewis, H. Zywicke, B. Miller, P. van Gelderen, B. M. Moskowitz, I. D. Duncan, and J. A. Frank, "Magnetodendrimers allow endosomal magnetic labeling and in vivo tracking of stem cells," Nat. Biotechnol., vol. 19, pp. 1141-1147, 2001.
21. J. W. Bulte, Y. Hoekstra, R. L. Kamman, R. L. Magin, A. G. Webb, R. W. Briggs, K. G. Go, C. E. Hulstaert, S. Miltenyi, and T. H. The, "Specific MR imaging of human lymphocytes by monoclonal antibody-guided dextran-magnetite particles," Magn. Reson. Med., vol. 25, pp. 148-157, 1992.
22. H. W. Kang, L. Josephson, A. Petrovsky, R. Weissleder, and A. Bogdanov, Jr., "Magnetic resonance imaging of inducible E-selectin expression in human endothelial cell culture," Bioconjug. Chem., vol. 13, pp. 122-127, 2002.
23. D. Artemov, N. Mori, B. Okollie, and Z. M. Bhujwalla, "MR molecular imaging of the Her-2/neu receptor in breast cancer cells using targeted iron oxide nanoparticles," Magn. Reson. Med., vol. 49, pp. 403-408, 2003.
24. M. Zhao, D. A. Beauregard, L. Loizou, B. Davletov, and K. M. Brindle, "Non-invasive detection of apoptosis using magnetic resonance imaging and a targeted contrast agent," Nat. Med., vol. 7, pp. 1241-1244, 2001.
25. R. Weissleder, A. Moore, U. Mahmood, R. Bhorade, H. Benveniste, E. A. Chiocca, and J. P. Basilion, "In vivo magnetic resonance imaging of transgene expression," Nat. Med., vol. 6, pp. 351-355, 2000.
26. L. D. Stegman, A. Rehemtulla, B. Beattie, E. Kievit, T. S. Lawrence, R. G. Blasberg, J. G. Tjuvajev, and B. D. Ross, "Noninvasive quantitation of cytosine deaminase transgene expression in human tumor xenografts with in vivo magnetic resonance spectroscopy," Proc. Nat. Acad. Sci. USA, vol. 96, pp. 9821-9826, 1999.
27. E. O. Aboagye, D. Artemov, P. Senter, and Z. M. Bhujwalla, "Intratumoral conversion of 5-fluorocytosine to 5-fluorouracil by monoclonal antibody-cytosine deaminase conjugates: Noninvasive detection of prodrug activation by magnetic resonance spectroscopy and spectroscopic imaging," Cancer Res., vol. 58, pp. 4075-4078, 1998.
28. V. Guivel-Scharen, T. Sinnwell, S. D. Wolff, and R. S. Balaban, "Detection of proton chemical exchange between metabolites and water in biological tissues," J. Magn. Reson., vol. 133, pp. 36-45, 1998.
29. K. M. Ward and R. S. Balaban, "Determination of pH using water protons and chemical exchange dependent saturation transfer (CEST)," Magn. Reson. Med., vol. 44, pp. 799-802, 2000.
30. N. Goffeney, J. W. Bulte, J. Duyn, L. H. Bryant, Jr., and P. C. van Zijl, "Sensitive NMR detection of cationic-polymer-based gene delivery systems using saturation transfer via proton exchange," J. Amer. Chem. Soc., vol. 123, pp. 8628-8629, 2001.
31. K. Snoussi, J. W. Bulte, M. Gueron, and P. C. Van Zijl, "Sensitive CEST agents based on nucleic acid imino proton exchange: Detection of poly(rU) and of a dendrimer-poly(rU) model for nucleic acid delivery and pharmacology," Magn. Reson. Med., vol. 49, pp. 998-1005, 2003.
32. S. C. Chu, M. M. Pike, E. T. Fossel, T. W. Smith, J. A. Balschi, and C. S. Springer, Jr., "Aqeous shift-reagents for high-resolution cationic nuclear magnetic-resonance 3. DY(TTHA)3-, TM(TTHA)3-, and TM(PPP)27-," J. Magn. Reson., vol. 56, pp. 33-47, 1984.
33. S. Zhang, P. Winter, K. Wu, and A. D. Sherry, "A novel europium(III)-based MRI contrast agent," J. Amer. Chem. Soc., vol. 123, pp. 1517-1518, 2001.
34. R. K. Jain, "Transport of molecules across tumor vasculature," Cancer Metastasis Rev., vol. 6, pp. 559-593, 1987.
35. _, "Determinants of tumor blood flow: A review," Cancer Res., vol. 48, pp. 2641-2658, 1988.
36. P. Vaupel, F. Kallinowski, and P. Okunieff, "Blood flow, oxygen and nutrient supply, and metabolic microenvironment of human tumors: A review," Cancer Res., vol. 49, pp. 6449-6465, 1989.
37. H. J. Aronen, M. S. Cohen, J. W. Belliveau, J. A. Fordham, and B. R. Rosen, "Ultrafast imaging of brain tumors," Top Magn. Reson. Imag., vol. 5, pp. 14-24, 1993.
38. H. Hawighorst, P. G. Knapstein, W. Weikel, M. V. Knopp, J. Zuna, A. Knof, G. Brix, U. Schaeffer, C. Wilkens, S. O. Schoenberg, M. Essig, P. Vaupel, and G. van Kaick, "Angiogenesis of uterine cervical carcinoma: Characterization by pharmacokinetic magnetic resonance parameters and histological microvessel density with correlation to lymphatic involvement," Cancer Res., vol. 57, pp. 4777-4786, 1997.
39. H. Degani, V. Gusis, D. Weinstein, S. Fields, and S. Strano, "Mapping pathophysiological features of breast tumors by MRI at high spatial resolution," Nat. Med., vol. 3, pp. 780-782, 1997.
40. P. S. Tofts, "Modeling tracer kinetics in dynamic Gd-DTPA MR imaging," J. MRI, vol. 7, pp. 91-101, 1997.
41. P. S. Tofts, G. Brix, D. L. Buckley, J. L. Evelhoch, E. Henderson, M. V. Knopp, H. B. Larsson, T. Y. Lee, N. A. Mayr, G. J. Parker, R. E. Port, J. Taylor, and R. M. Weisskoff, "Estimating kinetic parameters from dynamic contrast-enhanced T(1)-weighted MRI of a diffusable tracer: Standardized quantities and symbols," J. MRI, vol. 10, pp. 223-232, 1999.
42. M. Maeda, S. Itoh, H. Kimura, T. Iwasaki, N. Hayashi, K. Yamamoto, Y. Ishii, and T. Kubota, "Tumor vascularity in the brain: Evaluation with dynamic susceptibility-contrast MR imaging," Radiology, vol. 189, pp. 233-238, 1993.
43. H. J. Aronen, I. E. Gazit, D. N. Louis, B. R. Buchbinder, F. S. Pardo, R. M. Weisskoff, G. R. Harsh, G. R. Cosgrove, E. F. Halpern, F. H. Hochberg, and B. R. Rosen, "Cerebral blood volume maps of gliomas: Comparison with tumor grade and histological findings," Radiology, vol. 191, pp. 41-51, 1994.
44. J. P. Eder, Jr., J. G. Supko, J. W. Clark, T. A. Puchalski, R. Garcia-Carbonero, D. P. Ryan, L. N. Shulman, J. Proper, M. Kirvan, B. Rattner, S. Connors, M. T. Keogan, M. J. Janicek, W. E. Fogler, L. Schnipper, N. Kinchla, C. Sidor, E. Phillips, J. Folkman, and D. W. Kufe, "Phase I clinical trial of recombinant human endostatin administered as a short intravenous infusion repeated daily," J. Clin. Oncol, vol. 20, pp. 3772-3784, 2002.
45. G. C. Jayson, J. Zweit, A. Jackson, C. Mulatero, P. Julyan, M. Ranson, L. Broughton, J. Wagstaff, L. Hakannson, G. Groenewegen, J. Bailey, N. Smith, D. Hastings, J. Lawrance, H. Haroon, T. Ward, A. T. McGown, M. Tang, D. Levitt, S. Marreaud, F. F. Lehmann, M. Herold, and H. Zwierzina, "Molecular imaging and biological evaluation of HuMV833 anti-VEGF antibody: Implications for trial design of antiangiogenic antibodies," J. Nat. Cancer Inst., vol. 94, pp. 1484-1493, 2002.
46. R. M. Weisskoff, C. S. Zuo, J. L. Boxerman, and B. R. Rosen, "Microscopic susceptibility variation and transverse relaxation: Theory and experiment," Magn. Reson. Med., vol. 31, pp. 601-610, 1994.
47. J. L. Boxerman, L. M. Hamberg, B. R. Rosen, and R. M. Weisskoff, "MR contrast due to intravascular magnetic susceptibility perturbations," Magn. Reson. Med., vol. 34, pp. 555-566, 1995.
48. J. Dennie, J. B. Mandeville, J. L. Boxerman, S. D. Packard, B. R. Rosen, and R. M. Weisskoff, "NMR imaging of changes in vascular morphology due to tumor angiogenesis," Magn. Reson. Med., vol. 40, pp. 793-799, 1998.
49. B. R. Rosen, J. W. Belliveau, B. R. Buchbinder, R. C. McKinstry, L. M. Porkka, D. N. Kennedy, M. S. Neuder, C. R. Fisel, H. J. Aronen, K. K. Kwong, R. M. Weisskoff, M. S. Cohen, and T. J. Brady, "Contrast agents and cerebral hemodynamics," Magn. Reson. Med., vol. 19, pp. 285-292, 1991.
50. K. M. Donahue, H. G. J. Krouwer, S. D. Rand, A. P. Pathak, C. S. Marzalkowski, S. C. Censky, and R. W. Prost, "Utility of simultaneously-acquired gradient-echo and spin-echo cerebral blood volume and morphology maps in brain tumor patients," Mag. Reson. Med., vol. 43, pp. 845-853, 2000.
51. K. M. Donahue, R. M. Weisskoff, D. A. Chesler, K. K. Kwong, A. A. Bogdanov, J. B. Mandeville, and B. R. Rosen, "Improving MR quantitation of regional blood volume with intravascular T1 contrast agents: Accuracy, precision, and water exchange," Magn. Reson. Med., vol. 36, pp. 858-867, 1996.
52. C. S. Landis, X. Li, F. W. Telang, P. E. Molina, I. Palyka, G. Vetek, and C. S. Springer, Jr., "Equilibrium transcytolemmal water-exchange kinetics in skeletal muscle in vivo" Magn. Reson. Med., vol. 42, pp. 467-478, 1999.
53. T. E. Yankeelov, W. D. Rooney, X. Li, and C. S. Springer, Jr., "Variation of the relaxographic "shutter-speed" for transcytolemmal water exchange affects the CR bolus-tracking curve shape," Magn. Reson. Med., vol. 50, pp. 1151-1169, 2003.
54. R. Brasch, C. Pham, D. Shames, T. Roberts, K. van Dijke, N. van Bruggen, J. Mann, S. Ostrowitzki, and O. Melnyk, "Assessing tumor angiogenesis using macromolecular MR imaging contrast media," J. Magn. Reson. Imag., vol. 7, pp. 68-74, 1997.
55. A. P. Pathak, D. Artemov, and Z. M. Bhujwalla, "Novel system for determining contrast agent concentration in mouse blood in vivo" Magn. Reson. Med., vol. 51, pp. 612-615, 2004.
56. F. Demsar, T. P. Roberts, H. C. Schwickert, D. M. Shames, C. F. van Dijke, J. S. Mann, M. Saeed, and R. C. Brasch, "A MRI spatial mapping technique for microvascular permeability and tissue blood volume based on macromolecular contrast agent distribution," Magn. Reson. Med., vol. 37, pp. 236-242, 1997.
57. K. Turetschek, E. Floyd, D. M. Shames, T. P. Roberts, A. Preda, V. Novikov, C. Corot, W. O. Carter, and R. C. Brasch, "Assessment of a rapid clearance blood pool MR contrast medium (P792) for assays of microvascular characteristics in experimental breast tumors with correlations to histopathology," Magn. Reson. Med., vol. 45, pp. 880-886, 2001.
58. Y. R. Kim, K. J. Rebro, and K. M. Schmainda, "Water exchange and inflow affect the accuracy of T1-GRE blood volume measurements: Implications for the evaluation of tumor angiogenesis," Magn. Reson. Med., vol. 47, pp. 1110-1120, 2002.
59. H. C. Schwickert, T. P. Roberts, D. M. Shames, C. F. van Dijke, A. Disston, A. Muhler, J. S. Mann, and R. C. Brasch, "Quantification of liver blood volume: Comparison of ultra short TI inversion recovery echo planar imaging (ULSTIR-EPI), with dynamic 3D-gradient re-called echo imaging," Magn. Reson. Med., vol. 34, pp. 845-852, 1995.
60. S. Ogawa, "Oxygenation-sensitive contrast in MR image of rodent brain at high magnetic fields," Magn. Reson. Med., vol. 14, pp. 68-78, 1990.
61. R. Abramovitch, H. Dafni, E. Smouha, L. Benjamin, and M. Neeman, "In vivo prediction of vascular susceptibility to vascular endothelial growth factor withdrawal: Magnetic resonance imaging of C6 rat glioma in nude mice," Cancer Res., vol. 59, pp. 5012-5016, 1999.
62. P. Carmeliet, Y. Dor, J.-M. Herbert, D. Fukumura, K. Brusselmans, M. Dewerchin, M. Neeman, F. Bono, R. Abramovitch, P. Maxwell, C. J. Koch, P. Ratcliffe, L. Moons, R. K. Jain, D. Collen, and E. Keshet, "Role of HIF-1 in hypoxia-mediated apoptosis, cell proliferation and tumor angiogenesis," Nature, vol. 394, pp. 485-490, 1998.
63. A. P. Pathak, B. D. Ward, K. J. Rebro, and K. M. Schmainda, "The effect of brain tumor angiogenesis on the in vivo relationship between contrast agent (MION) dose and the gradient echo relaxation rate change (ΔR2*)," J. MRI, 2003.
64. A. C. Silva, S.-G. Kim, and M. Garwood, "Imaging blood flow in brain tumors using arterial spin labeling," Magn. Reson. Med., vol. 44, pp. 169-173, 2000.
65. M. C. Preul, Z. Caramanos, J. G. Villemure, G. Shenouda, R. LeBlanc, A. Langleben, and D. L. Arnold, "Using proton magnetic resonance spectroscopic imaging to predict in vivo the response of recurrent malignant gliomas to tamoxifen chemotherapy," Neurosurgery, vol. 46, pp. 306-318, 2000.
66. S. J. Nelson, E. Graves, A. Pirzkall, X. Li, A. Antiniw Chan, D. B. Vigneron, and T. R. McKnight, "In vivo molecular imaging for planning radiation therapy of gliomas: An application of 1H MRSI," J. Magn. Reson. Imag., vol. 16, pp. 464-476, 2002.
67. I. Tkac, Z. Starcuk, I. Y. Choi, and R. Cruetter, "In vivo 1H NMR spectroscopy of rat brain at 1 ms echo time," Magn. Reson. Med., vol. 41, pp. 649-656, 1999.
68. A. Haase, J. Frahm, W. Hanicke, and D. Matthaei, "1H NMR chemical shift selective (CHESS) imaging," Phys. Med. Biol., vol. 30, pp. 341-344, 1985.
69. P. A. Bottomley, Ann. N.Y. Acad. Sci., vol. 508, 1984.
70. D. C. Shungu and J. D. Glickson, "Band-selective spin echoes for in vivo localized 1H NMR spectroscopy," Magn. Reson. Med., vol. 32, pp. 277-284, 1994.
71. J. Slar-Lack, S. J. Nelson, J. Kurhanewicz, L. R. Huang, and D. B. Vigneron, "Improved water and lipid suppression for 3D PRESS CSI using RF band selective inversion with gradient dephasing (BASING)," Magn. Reson. Med., vol. 38, pp. 311-321, 1997.
72. R. Callies, R. M. Sri-Pathmanathan, D. Y. Ferguson, and K. M. Brindle, "The appearance of neutral lipid signals in the 1H NMR spectra of a myeloma cell line correlates with the induced formation of cytoplasmic lipid droplels," Magn. Reson. Med., vol. 29, pp. 546-550, 1993.
73. I. Barba, M. E. Cabanas, and C. Arus, "The relationship belween nuclear magnetic resonance-visible lipids, lipid droplels, and cell proliferation in cultured C6 cells," Cancer Res., vol. 59, pp. 1861-1868, 1999.
74. N. M. Al-Saffar, J. C. Titley, D. Robertson, P. A. Clarke, L. E. Jackson, M. O. Leach, and S. M. Ronen, "Apoptosis is associated with triacylglycerol accumulation in Jurkat T-cells," Brit. J. Cancer, vol. 86, pp. 963-970, 2002.
75. C. H. Sotak, "A volume-localized, two-dimensional NMR method for the determination of lactale using zero-quanlum coherence created in a stimulated echo pulse sequence," Magn. Reson. Med., vol. 7, pp. 364-370, 1988.
76. R. E. Hurd and D. Freeman, "Proton editing and imaging of lactate," NMR Biomed., vol. 4, pp. 73-80, 1991.
77. R. A. de Graaf, Y. Luo, M. Terpstra, and M. Garwood, "Spectral editing with adiabatic pulses," J. Magn. Reson. B, vol. 109, pp. 184-193, 1995.
78. Z. M. Bhujwalla, D. C. Shungu, and J. D. Glickson, "Effects of blood flow modifiers on tumor metabolism observed in vivo by proton magnetic resonance spectroscopic imaging,"Magn. Reson. Med., vol. 36, pp. 204-211, 1996.
79. Q. He, D. C. Shungu, P. C. van Zijl, Z. M. Bhujwalla, and J. D. Glickson, "Single-scan in vivo lactate editing with complete lipid and water suppression by selective multiple-quantum-coherence transfer (Sel-MQC) with application to tumors," J. Magn. Reson. B, vol. 106, pp. 203-211, 1995.
80. Q. He, Z. M. Bhujwalla, R. J. Maxwell, J. R. Griffiths, and J. D. Glickson, "Proton NMR observation of the antineoplastic agent Iproplatin in vivo by selective multiple quantum coherence transfer (Sel-MQC)," Magn. Reson. Med., vol. 33, pp. 414-416, 1995.
81. W. Negendank, "Studies of human tumors by MRS: A review," NMR Biomed., vol. 5, pp. 303-324, 1992.
82. I. S. Gribbestad, B. Sitter, S. Lundgren, J. Krane, and D. Axelson, "Metabolite composition in breast tumors examined by proton nuclear magnetic resonance spectroscopy," Anticancer Res., vol. 19, pp. 1737-1746, 1999.
83. E. O. Aboagye and Z. M. Bhujwalla, "Malignant transformation alters membrane choline phospholipid metabolism of human mammary epithelial cells," Cancer Res., vol. 59, pp. 80-84, 1999.
84. R. Katz-Brull and H. Degani, "Kinetics of choline transport and phosphorylation in human breast cancer cells: NMR application of the zero trans method," Anticancer Res., vol. 16, pp. 1375-1380, 1996.
85. A. Ramirez de Molina, R. Gutierrez, M. A. Ramos, J. M. Silva, J. Silva, F. Bonilla, J. J. Sanchez, and J. C. Lacal, "Increased choline kinase activity in human breast carcinomas: Clinical evidence for a potential novel antitumor strategy," Oncogene, vol. 21, pp. 4317-4322, 2002.
86. A. Ramirez de Molina, A. Rodriguez-Gonzalez, R. Gutierrez, L. Martinez-Pineiro, J. Sanchez, F. Bonilla, R. Rosell, and J. Lacal, "Overexpression of choline kinase is a frequent feature in human tumor-derived cell lines and in lung, prostate, and colorectal human cancers," Kochern. Biophys. Res. Commun., vol. 296, pp. 580-583, 2002.
87. S. Yamashita, J. Yamashita, and M. Ogawa, "Overexpression of group II phospholipase A2 in human breast cancer tissues is closely associated with their malignant potency," Brit. J. Cancer, vol. 69, pp. 1166-1170, 1994.
88. C. J. Guthridge, M. R. Stampfer, M. A. Clark, and M. R. Steiner, "Phospholipases A2 in ras-transformed and immortalized human mammary epithelial cells," Cancer Lett., vol. 86, pp. 11-21, 1994.
89. N. Uchida, S. Okamura, Y. Nagamachi, and S. Yamashita, "Increased phospholipase D activity in human breast cancer," J. Cancer Res. Clin. Oncol., vol. 123, pp. 280-285, 1997.
90. D. Y. Noh, S. J. Ahn, R. A. Lee, I. A. Park, J. H. Kim, P. G. Suh, S. H. Ryu, K. H. Lee, and J. S. Han, "Overexpression of phospholipase D1 in human breast cancer tissues," Cancer Lett., vol. 161, pp. 207-214, 2000.
91. E. Ackerstaff, K. Glunde, and Z. M. Bhujwalla, "Choline phospholipid metabolism: A target in cancer cells?," J. Cell Biochem., vol. 90, pp. 525-533, 2003.
92. R. Katz-Brull, P. T. Lavin, and R. E. Lenkinski, "Clinical utility of proton magnetic resonance spectroscopy in characterizing breast lesions," J. Nat. Cancer Inst., vol. 94, pp. 1197-1203, 2002.
93. J. Kurhanewicz, D. B. Vigneron, and S. J. Nelson, "Three-dimensional magnetic resonance spectroscopic imaging of brain and prostate cancer," Neoplasia, vol. 2, pp. 166-189, 2000.
94. X. Li, Y. Lu, A. Pirzkall, T. McKnight, and S. J. Nelson, "Analysis of the spatial characteristics of metabolic abnormalities in newly diagnosed glioma patients," J. Magn. Reson. Imag., vol. 16, pp. 229-237, 2002.
95. D. Artemov, Z. M. Bhujwalla, U. Pilatus, and J. D. Glickson, "Two-compartment model for determination of glycolytic rates of solid tumors by in vivo 13C NMR spectroscopy," NMR Biomed., vol. 11, pp. 395-404, 1998.
96. F. U. Nielsen, P. Daugaard, L. Bentzen, H. Stodkilde-Jorgensen, J. Overgaard, M. R. Horsman, and R. J. Maxwell, "Effect of changing tumor oxygenation on glycolytic metabolism in a murine C3H mammary carcinoma assessed by in vivo nuclear magnetic resonance spectroscopy," Cancer Res., vol. 61, pp. 5318-5325, 2001.
97. R. Katz-Brull, R. Margalit, and H. Degani, "Differential routing of choline in implanted breast cancer and normal organs," Magn. Reson. Med., vol. 46, pp. 31-38, 2001.
98. S. M. Ronen and H. Degani, "The application of 13C NMR to the characterization of phospholipid metabolism in cells," Magn. Reson. Med., vol. 25, pp. 384-389, 1992.
99. I. Constantinidis, J. C. Chatham, J. P. Wehrle, and J. D. Glickson, "In vivo 13CNMR spectroscopy of glucose metabolism of RIF-1 tumors," Magn. Reson. Med., vol. 20, pp. 17-26, 1991.
100. Z. M. Bhujwalla, I. Constantinidis, J. C. Chatham, J. P. Wehrle, and J. D. Glickson, "Energy metabolism, pH changes, and lactate production in RIF-1 tumors following intratumoral injection of glucose," Int. J. Radiat. Oncol. Biol Phys., vol. 22, pp. 95-101, 1992.
101. D. G. Schupp, H. Merkle, J. M. Ellermann, Y. Ke, and M. Garwood, "Localized detection of glioma glycolysis using edited 1H MRS," Magn. Reson. Med., vol. 30, pp. 18-27, 1993.
102. S. M. Ronen, A. Volk, and J. Mispelter, "Comparative NMR study of a differentiated rat hepatoma and its dedifferentiated subclone cultured as spheroids and as implanted tumors," NMR Biomed., vol. 7, pp. 278-286, 1994.
103. M. Terpstra, W. B. High, Y. Luo, R. A. de Graaf, H. Merkle, and M. Garwood, "Relationships among lactate concentration, blood flow and histopathologic profiles in rat C6 glioma," NMR Biomed., vol. 9, pp. 185-194, 1996.
104. P. A. Bottomley, C. J. Hardy, P. B. Roemer, and O. M. Mueller, "Proton-decoupled, overhauser-enhanced, spatially localized carbon-13 spectroscopy in humans," Magn. Reson. Med., vol. 12, pp. 348-363, 1989.
105. D. L. Rothman, K. L. Behar, H. P. Hetherington, J. A. den Hollander, M. R. Bendall, O. A. Petroff, andR. G. Shulman, "1H-Observe/13C-decouple spectroscopic measurements of lactate and glutamate in the rat brain in vivo," Proc. Nat. Acad. Sci. USA, vol. 82, pp. 1633-1637, 1985.
106. P. C. van Zijl, A. S. Chesnick, D. DesPres, C. T. Moonen, J. Ruiz-Cabello, and P. van Gelderen, "In vivo proton spectroscopy and spectroscopic imaging of [1-13 C]-glucose and its metabolic products," Magn. Reson. Med., vol. 30, pp. 544-551, 1993.
107. D. Artemov, Z. M. Bhujwalla, and J. D. Glickson, "In vivo selective measurement of (1-13 C)-glucose metabolism in tumors by heteronuclear cross polarization," Magn. Reson. Med., vol. 33, pp. 151-155, 1995.
108. M. O. Leach, M. Verrill, J. Glaholm, T. A. Smith, D. J. Collins, G. S. Payne, J. C. Sharp, S. M. Ronen, V. R. McCready, T. J. Powles, and I. E. Smith, "Measurements of human breast cancer using magnetic resonance spectroscopy: A review of clinical measurements and a report of localized 31P measurements of response to treatment," NMR Biomed., vol. 11, pp. 314-340, 1998.
109. P. G. Okunieff, J. A. Koutcher, L. Gerweck, E. McFarland, B. Hitzig, M. Urano, T. Brady, L. Neuringer, and H. D. Suit, "Tumor size dependent changes in a murine fibrosarcoma: Use of in vivo 3IP NMR for noninvasive evaluation of tumor metabolic status," Int. J. Radial. Oncol. Biol. Phys., vol. 12, pp. 793-799, 1986.
110. S. J. Li, J. P. Wehrle, S. S. Rajan, R. G. Steen, J. D. Glickson, and J. Hilton, "Response of radiation-induced fibrosarcoma-1 in mice to cyclophosphamide monitored by in vivo 31P nuclear magnetic resonance spectroscopy," Cancer Res., vol. 48, pp. 4736-4742, 1988.
111. P. Vaupel, P. Okunieff, F. Kallinowski, and L. J. Neuringer, "Correlations between 31P-NMR spectroscopy and tissue O2 tension measurements in a murine fibrosarcoma," Radiat Res., vol. 120, pp. 477-493, 1989.
112. E. K. Rofstad, P. DeMuth, B. M. Fenton, and R. M. Sutherland, "3 IP nuclear magnetic resonance spectroscopy studies of tumor energy metabolism and its relationship to intracapillary oxyhemoglobin saturation status and tumor hypoxia," Cancer Res, vol. 48, pp. 5440-5446, 1988.
113. G. M. Tozer, Z. M. Bhujwalla, J. R. Griffiths, and R. J. Maxwell, "Phosphorus-31 magnetic resonance spectroscopy and blood perfusion of the RIF-1 tumor following X-irradiation," Int. J. Radiat. Oncol. Biol. Phys., vol. 16, pp. 155-164, 1989.
114. J. D. de Certaines, V. A. Larsen, F. Podo, G. Carpinelli, O. Briot, and O. Henriksen, "In vivo 3IP MRS of experimental tumours," NMR Biomed., vol. 6, pp. 345-365, 1993.
115. F. Podo, "Tumour phospholipid metabolism," NMR Biomed., vol. 12, pp. 413-439, 1999.
116. S. M. Ronen, L. E. Jackson, M. Beloueche, and M. O. Leach, "Magnetic resonance detects changes in phosphocholine associated with Ras activation and inhibition in NIH 3T3 cells," Brit. J. Cancer, vol. 84, pp. 691-696, 2001.
117. K. Glunde, E. Ackerstaff, K. Natarajan, D. Artemov, and Z. M. Bhujwalla, "Real-time changes in 1H and 31P NMR spectra of malignant human mammary epithelial cells during treatment with the anti-in-flammatory agent indomethacin," Magn. Reson. Med., vol. 48, pp. 819-825, 2002.
118. M. Sterin, J. S. Cohen, Y. Mardor, E. Berman, and I. Ringel, "Levels of phospholipid metabolites in breast cancer cells treated with antimitotic drugs: A (31)p-magnetic resonance spectroscopy study," Cancer Res., vol. 61, pp. 7536-7543, 2001.
119. R. B. Moon and J. H. Richards, "Determination of intracellular pH by 31P magnetic resonance," J. Biol. Chem., vol. 248, pp. 7276-7278, 1973.
120. M. Stubbs, Z. M. Bhujwalla, G. M. Tozer, L. M. Rodrigues, R. J. Maxwell, R. Morgan, F. A. Howe, and J. R. Griffiths, "An assessment of 31P MRS as a method of measuring pH in rat tumours," NMR Biomed., vol. 5, pp. 351-359, 1992.
121. R. J. Gillies, Z. Liu, and Z. Bhujwalla, "31P-MRS measurements of extracellular pH of tumors using 3-aminopropylphosphonate," Amer. J. Physiol, vol. 267, pp. C195-C203, 1994.
122. R. J. Gillies, T. Ogino, R. G. Shulman, and D. C. Ward, "3 IP nuclear magnetic resonance evidence for the regulation of intracellular pH by Ehrlich ascites tumor cells," J. Cell Biol., vol. 95, pp. 24-28, 1982.
123. R. Martinez-Zaguilan, R. M. Lynch, G. M. Martinez, and R. J. Gillies, "Vacuolar-type H(+)-ATPases are functionally expressed in plasma membranes of human tumor cells," Amer. J. Physiol., vol. 265, pp. C1015-C1029, 1993.
124. S. R. Sennoune, K. Bakunts, G. M. Martinez, J. L. Chua-Tuan, Y. Kebir, M. N. Attaya, and R. Martinez-Zaguilan, "Vacuolar H+-AT-Pase in human breast cancer cells with distinct metastatic potential: Distribution and functional activity," Amer. J. Physiol. Cell Physiol., 2004.
125. G. M. Tozer, R. J. Maxwell, J. R. Griffiths, and P. Pham, "Modification of the 31P magnetic resonance spectra of a rat tumour using vasodilators and its relationship to hypotension," Brit. J. Cancer, vol. 62, pp. 553-560, 1990.
126. Z. M. Bhujwalla, G. M. Tozer, S. B. Field, R. J. Maxwell, and J. R. Griffiths, "The energy metabolism of RIF-1 tumours following hydralazine," Radiother. Oncol., vol. 19, pp. 281-291, 1990.
127. R. van Sluis, Z. M. Bhujwalla, N. Raghunand, P. Ballesteros, J. Alvarez, S. Cerdan, J. P. Galons, and R. J. Gillies, "In vivo imaging of extracellular pH using 1H MRSI," Magn. Reson. Med., vol. 41, pp. 743-750, 1999.
128. Z. M. Bhujwalla, D. Artemov, P. Ballesteros, S. Cerdan, R. J. Gillies, and M. Solaiyappan, "Combined vascular and extracellular pH imaging of solid tumors," NMR Biomed., vol. 15, pp. 114-119, 2002.
129. M. L. Garcia-Martin, G. Herigault, C. Remy, R. Farion, P. Ballesteros, J. A. Coles, S. Cerdan, and A. Ziegler, "Mapping extracellular pH in rat brain gliomas in vivo by 1H magnetic resonance spectroscopic imaging: Comparison with maps of metabolites," Cancer Res., vol. 61, pp. 6524-6531, 2001.
130. J. Zhou, J. F. Payen, D. A. Wilson, R. J. Traystman, and P. C. van Zijl, "Using the amide proton signals of intracellular proteins and peptides to detect pH effects in MRI," Nat. Med., vol. 9, pp. 1085-1090, 2003.
131. H. B. Larsson, T. Fritz-Hansen, E. Rostrup, L. Sondergaard, P. Ring, and O. Henriksen, "Myocardial perfusion modeling using MRI," Magn. Reson. Med., vol. 35, pp. 716-726, 1996.
132. E. Henderson, J. Sykes, D. Drost, H. J. Weinmann, B. K. Rutt, and T. Y. Lee, "Simultaneous MRI measurement of blood flow, blood volume, and capillary permeability in mammary tumors using two different contrast agents," J. Magn. Reson. Imag., vol. 12, pp. 991-1003, 2000.
133. A. G. Sorensen, A. L. Tievsky, L. Ostergaard, R. M. Weisskoff, and B. R. Rosen, "Contrast agents in functional MR imaging," J. Magn. Reson. Imag., vol. 7, pp. 47-55, 1997.
134. R. M. Weisskoff, "Pitfalls in MR measurement of tissue blood flow with intravascular tracers: Which mean transit time," Magn. Reson. Med., vol. 29, pp. 553-559, 1993.
135. L. Ostergaard, R. M. Weisskoff, D. A. Chester, C. Gyldensted, and B. R. Rosen, "High resolution measurement of cerebral blood flow using intravascular tracer bolus passages. Part I: Mathematical approach and statistical analysis," Magn. Reson. Med., vol. 36, pp. 715-725, 1996.